Journal of the American Academy of Dermatology
-
J. Am. Acad. Dermatol. · Oct 2017
Multicenter StudyLong-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Long-term topical treatment is often required for atopic dermatitis (AD), a chronic inflammatory skin disease. ⋯ Crisaborole ointment had a low frequency of treatment-related AEs over 48 weeks of treatment of patients with AD.